scholarly journals A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivo

Blood ◽  
2012 ◽  
Vol 119 (11) ◽  
pp. 2545-2551 ◽  
Author(s):  
Vivienne B. Gibson ◽  
Robert A. Benson ◽  
Karen J. Bryson ◽  
Iain B. McInnes ◽  
Catherine M. Rush ◽  
...  

Abstract In vivo imaging has revolutionized understanding of the spatiotemporal complexity that subserves the generation of successful effector and regulatory immune responses. Until now, invasive surgery has been required for microscopic access to lymph nodes (LNs), making repeated imaging of the same animal impractical and potentially affecting lymphocyte behavior. To allow longitudinal in vivo imaging, we conceived the novel approach of transplanting LNs into the mouse ear pinna. Transplanted LNs maintain the structural and cellular organization of conventional secondary lymphoid organs. They participate in lymphocyte recirculation and exhibit the capacity to receive and respond to local antigenic challenge. The same LN could be repeatedly imaged through time without the requirement for surgical exposure, and the dynamic behavior of the cells within the transplanted LN could be characterized. Crucially, the use of blood vessels as fiducial markers also allowed precise re-registration of the same regions for longitudinal imaging. Thus, we provide the first demonstration of a method for repeated, noninvasive, in vivo imaging of lymphocyte behavior.

Glia ◽  
2018 ◽  
Vol 66 (8) ◽  
pp. 1611-1624 ◽  
Author(s):  
Lorena Colás ◽  
Maria Domercq ◽  
Pedro Ramos-Cabrer ◽  
Ana Palma ◽  
Vanessa Gómez-Vallejo ◽  
...  

2013 ◽  
Vol 88 (4) ◽  
pp. 1924-1934 ◽  
Author(s):  
Q. Wang ◽  
W. Jiang ◽  
Y. Chen ◽  
P. Liu ◽  
C. Sheng ◽  
...  

2017 ◽  
Vol 55 (2) ◽  
pp. 429-435 ◽  
Author(s):  
Alicia Cawlfield ◽  
Brian Vesely ◽  
Franklyn Ngundam ◽  
Kirk Butler ◽  
Dylan Nugent ◽  
...  

2008 ◽  
Vol 4 ◽  
pp. T300-T301
Author(s):  
Paul B. Rosenberg ◽  
Y. Zhou ◽  
A. Kumar ◽  
H.T. Ravert ◽  
J. Brasic ◽  
...  

2017 ◽  
Vol 8 (5) ◽  
pp. 774-785 ◽  
Author(s):  
István Kertész ◽  
András Vida ◽  
Gábor Nagy ◽  
Miklós Emri ◽  
Antal Farkas ◽  
...  
Keyword(s):  

1990 ◽  
Vol 10 (1) ◽  
pp. 97-103 ◽  
Author(s):  
Fredric B. Meyer ◽  
Robert E. Anderson ◽  
Thoralf M. Sundt

The effects of the novel dihydronaphthyridine Ca2+ antagonist CI-951 on focal cerebral ischemia were assessed during MCA occlusion in 30 white New Zealand rabbits under 1.0% halothane anesthesia. In vivo brain pHi and focal CBF were measured with umbelliferone fluorescense. Baseline normocapnic brain pHi and CBF were 7.02 ± 0.02 and 48.4 ± 2.9 ml/100 g/min, respectively. In the severe ischemic regions, 15 min postocclusion brain pHi, and CBF were 6.62 ± 0.04 and 14.4 ± 0.7 ml/100 g/min in controls vs. 6.60 ± 0.02 and 12.9 ± 2.3 ml/100 g/min, respectively, in animals destined to receive CI-951. Twenty minutes after MCA occlusion, CI-951 was administered at 0.5 μg/kg/min and brain pHi and CBF were determined in both regions of severe and moderate ischemia for 4 h postocclusion. Control severe ischemic sites demonstrated no significant improvement in brain pHi and only mild increases in CBF over the next 4 h. CI-951 caused significant improvement in both of these parameters. Postocclusion 4 h brain pHi and CBF measured 6.69 ± 0.04 and 18.5 ± 3.2 ml/100 g/min in controls vs. 7.01 ± 0.04 and 41.7 ± 5.3 ml/100 g/min, respectively, in CI-951 animals ( p < 0.001). Similar improvements were observed in moderate ischemic sites. In animals that demonstrated postocclusion EEG attenuation, 75% of CI-951 animals had EEG recovery as compared to 18% in controls. CI-951 may be a useful therapeutic agent for focal cerebral ischemia if histological and outcome studies verify these data.


2015 ◽  
Vol 69 ◽  
pp. 61-71 ◽  
Author(s):  
Gábor Máté ◽  
István Kertész ◽  
Kata Nóra Enyedi ◽  
Gábor Mező ◽  
János Angyal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document